Bevers MSAM, Wyers CE, van Rietbergen B, van den Bergh JP, et al. Effects of romosozumab on the peripheral and axial skeleton in postmenopausal
women at high fracture risk: real-world evidence from DXA and HR-pQCT data. Osteoporos Int 2026 Sep 9. doi: 10.1007/s00198-026-08148.
PMID: 42711379
|